P-Rex1 participates in Neuregulin-ErbB signal transduction and its expression correlates with patient outcome in breast cancer

Oncogene

Volumn 30, Issue 9, 2011, Pages 1059-1071

  Montero, J C ^a   Seoane, S ^a   Ocaa A ^b   Pandiella, A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

Author keywords

breast cancer; ErbB; P Rex; tyrosine kinases

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRIPHOSPHATE DEPENDENT RAC EXCHANGER 1; REX PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL MOVEMENT; CELL PROLIFERATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; IMMUNOPRECIPITATION; MICE; MICE, NUDE; MOLECULAR TARGETED THERAPY; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; NEUREGULINS; ONCOGENE PROTEINS V-ERBB; PHOSPHORYLATION; PROGNOSIS; RAC GTP-BINDING PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 79952281692     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2010.489     Document Type: Article

References (31)

1. Adam L, Vadlamudi R, Kondapaka SB, Chernoff J, Mendelsohn J, Kumar R. (1998). Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phospha-tidylinositol-3 kinase. J Biol Chem 273: 28238-28246. (Pubitemid 28496122)
2. Atlas E, Cardillo M, Mehmi I, Zahedkargaran H, Tang C, Lupu R. (2003). Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo. Mol Cancer Res 1: 165-175. (Pubitemid 36330198)
3. Barber MA, Donald S, Thelen S, Anderson KE, Thelen M, Welch HC. (2007). Membrane translocation of P-Rex1 is mediated by G protein betagamma subunits and phosphoinositide 3-kinase. J Biol Chem 282: 29967-29976. (Pubitemid 350035293)
4. Baselga J, Arteaga CL. (2005). Critical update and emerging trends in epidermal growth factor receptor targeting in cancer. J Clin Oncol 23: 2445-2459. (Pubitemid 47050835)
5. Breuleux M. (2007). Role of heregulin in human cancer. Cell Mol Life Sci 64: 2358-2377. (Pubitemid 47402579)
6. Cabrera N, Diaz-Rodriguez E, Becker E, Martin-Zanca D, Pandiella A. (1996). TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment. J Cell Biol 132: 427-436. (Pubitemid 26053446)
7. Carraway III KL, Sliwkowski MX, Akita R, Platko JV, Guy PM, Nuijens A et al. (1994). The erbB3 gene product is a receptor for heregulin. J Biol Chem 269: 14303-14306. (Pubitemid 24191194)
8. de Alava E, Ocana A, Abad M, Montero JC, Esparis-Ogando A, Rodriguez CA et al. (2007). Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer. J Clin Oncol 25: 2656-2663. (Pubitemid 47123170)
9. Donald S, Hill K, Lecureuil C, Barnouin R, Krugmann S, John Coadwell W et al. (2004). P-Rex2, a new guanine-nucleotide exchange factor for Rac. FEBS Lett 572: 172-176. (Pubitemid 39092531)
10. Esparis-Ogando A, Diaz-Rodriguez E, Montero JC, Yuste L, Crespo P, Pandiella A. (2002). Erk5 participates in neuregulin signal transduction and is constitutively active in breast cancer cells overexpressing ErbB2. Mol Cell Biol 22: 270-285. (Pubitemid 33144274)
11. Esteva FJ, Yu D, Hung MC, Hortobagyi GN. (2009). Molecular predictors of response to trastuzumab and lapatinib in breast cancer. Nature Rev Clin Oncol 7: 98-107.
12. Fine B, Hodakoski C, Koujak S, Su T, Saal LH, Maurer M et al. (2009). Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Science 325: 1261-1265.
13. Hill K, Krugmann S, Andrews SR, Coadwell WJ, Finan P, Welch HC et al. (2005). Regulation of P-Rex1 by phosphatidylinositol (3,4,5)-trisphosphate and Gbetagamma subunits. J Biol Chem 280: 4166-4173. (Pubitemid 40288581)
14. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW et al. (1992). Identification of heregulin, a specific activator of p185erbB2. Science 256: 1205-1210.
15. Hynes NE, Lane HA. (2005). ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 5: 341-354. (Pubitemid 40637826)
16. Joseph RE, Norris FA. (2005). Substrate specificity and recognition is conferred by the pleckstrin homology domain of the Dbl family guanine nucleotide exchange factor P-Rex2. J Biol Chem 280: 27508-27512. (Pubitemid 41076861)
17. Krane IM, Leder P. (1996). NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12: 1781-1788. (Pubitemid 26146303)
18. Larsen MR, Thingholm TE, Jensen ON, Roepstorff P, Jorgensen TJ. (2005). Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 4: 873-886. (Pubitemid 41309146)
19. Massague J, Pandiella A. (1993). Membrane-anchored growth factors. Annu Rev Biochem 62: 515-541. (Pubitemid 23237880)
20. Mayeenuddin LH, Garrison JC. (2006). Phosphorylation of P-Rex1 by the cyclic AMP-dependent protein kinase inhibits the phosphatidy-linositiol (3,4,5)-trisphosphate and Gbetagamma-mediated regulation of its activity. J Biol Chem 281: 1921-1928. (Pubitemid 43845777)
21. Montero JC, Rodriguez-Barrueco R, Ocana A, Diaz-Rodriguez E, Esparis-Ogando A, Pandiella A. (2008). Neuregulins and cancer. Clin Cancer Res 14: 3237-3241.
22. Montero JC, Rodriguez-Barrueco R, Yuste L, Juanes PP, Borges J, Esparis-Ogando A et al. (2007). The extracellular linker of pro-neuregulin- alpha2c is required for efficient sorting and juxtacrine function. Mol Biol Cell 18: 380-393. (Pubitemid 46213209)
23. Qin J, Xie Y, Wang B, Hoshino M, Wolff DW, Zhao J et al. (2009). Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Oncogene 28: 1853-1863.
24. Rosenfeldt H, Vazquez-Prado J, Gutkind JS. (2004). P-REX2, a novel PI-3-kinase sensitive Rac exchange factor. FEBS Lett 572: 167-171. (Pubitemid 39092530)
25. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE et al. (1989). Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712. (Pubitemid 19147683)
26. Sliwkowski MX, Schaefer G, Akita RW, Lofgren JA, Fitzpatrick VD, Nuijens A et al. (1994). Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J Biol Chem 269: 14661-14665.
27. Tsai MS, Shamon-Taylor LA, Mehmi I, Tang CK, Lupu R. (2003). Blockage of heregulin expression inhibits tumorigenicity and metastasis of breast cancer. Oncogene 22: 761-768. (Pubitemid 36269290)
28. Welch HC, Coadwell WJ, Ellson CD, Ferguson GJ, Andrews SR, Erdjument-Bromage H et al. (2002). P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell 108: 809-821. (Pubitemid 34327532)
29. Yang C, Klein EA, Assoian RK, Kazanietz MG. (2008). Heregulin beta1 promotes breast cancer cell proliferation through Rac/ ERK-dependent induction of cyclin D1 and p21Cip1. Biochem J 410: 167-175. (Pubitemid 351300336)
30. Yang C, Liu Y, Lemmon MA, Kazanietz MG. (2006). Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4. Mol Cell Biol 26: 831-842. (Pubitemid 43146479)
31. Yuste L, Montero JC, Esparis-Ogando A, Pandiella A. (2005). Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin. Cancer Res 65: 6801-6810. (Pubitemid 41060718)